Form 4: Tyra Biosciences CFO Alan Fuhrman Acquires Shares Under Employee Stock Purchase Plan

Alan Fuhrman, CFO of Tyra Biosciences, acquired 954 shares of common stock through the company's Employee Stock Purchase Plan on September 13, 2024.

Summary

• On September 13, 2024, Alan Fuhrman, the Chief Financial Officer of Tyra Biosciences, acquired 954 shares of the company's common stock.
• The shares were purchased through the Issuer's 2021 Employee Stock Purchase Plan.
• The price per share was $12.478.
• Following the transaction, Fuhrman directly owns 3,349 shares of Tyra Biosciences.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a routine transaction under an employee stock purchase plan. It's a positive sign that the CFO is investing in the company, but it's not a major event.

Positives

• The CFO's participation in the Employee Stock Purchase Plan could be seen as a positive signal, indicating confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates confidence from a key executive.

Key Dates